Taiko Pharmaceutical Co., Ltd.TSE: 4574

Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (Under Japanese GAAP)

· Issued by Taiko Pharmaceutical Co., Ltd. via TDnet

Taiko Pharmaceutical Co., Ltd. (4574) Press Release

View Attachment

Company analysis

Earlier from Taiko Pharmaceutical

All Taiko Pharmaceutical news releases